STAG2 and myelodysplastic syndrome: A comparison between our defined mutational prognostic signature and both the IPSS-R and IPSS-M was assessed to evaluate whether the mutational status of STAG2, SRSF2 and RUNX1 could add value to these prognostic scoring systems in isolated +8 MDS.